Dr. Arthur Staddon, MD

NPI: 1588658942
Total Payments
$10,918
2018 Payments
$16.19
Companies
5
Transactions
11

Payment Breakdown by Category

Consulting$10,390 (95.2%)
Food & Beverage$502.00 (4.6%)
Travel$26.18 (0.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $10,390 4 95.2%
Food and Beverage $502.00 6 4.6%
Travel and Lodging $26.18 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Janssen Biotech, Inc. $7,390 3 $0 (2017)
Janssen Products, LP $3,355 5 $0 (2017)
Novartis Pharmaceuticals Corporation $125.00 1 $0 (2017)
Janssen Scientific Affairs, LLC $32.14 1 $0 (2017)
Merck Sharp & Dohme Corporation $16.19 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2018 $16.19 1 Merck Sharp & Dohme Corporation ($16.19)
2017 $10,902 10 Janssen Biotech, Inc. ($7,390)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
05/04/2018 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $16.19 General
11/20/2017 Janssen Products, LP YONDELIS (Drug) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: Oncology
11/10/2017 Janssen Products, LP YONDELIS (Drug) Food and Beverage In-kind items and services $118.16 General
Category: Oncology
11/10/2017 Janssen Products, LP YONDELIS (Drug) Travel and Lodging In-kind items and services $26.18 General
Category: Oncology
11/09/2017 Janssen Scientific Affairs, LLC PIPELINE (Device) Food and Beverage In-kind items and services $32.14 General
Category: Spine
11/08/2017 Janssen Products, LP YONDELIS (Drug) Food and Beverage In-kind items and services $114.96 General
Category: Oncology
11/08/2017 Janssen Products, LP YONDELIS (Drug) Food and Beverage In-kind items and services $95.55 General
Category: Oncology
10/03/2017 Janssen Biotech, Inc. YONDELIS (Drug) Consulting Fee Cash or cash equivalent $2,320.00 General
Category: Oncology
06/02/2017 Novartis Pharmaceuticals Corporation VOTRIENT (Drug) Food and Beverage In-kind items and services $125.00 General
Category: ONCOLOGY
05/25/2017 Janssen Biotech, Inc. YONDELIS (Drug) Consulting Fee Cash or cash equivalent $2,320.00 General
Category: Oncology
02/20/2017 Janssen Biotech, Inc. YONDELIS (Drug) Consulting Fee Cash or cash equivalent $2,750.00 General
Category: Oncology

About Dr. Arthur Staddon, MD

Dr. Arthur Staddon, MD is a Hematology & Oncology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588658942.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Staddon, MD has received a total of $10,918 in payments from pharmaceutical and medical device companies, with $16.19 received in 2018. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($10,390).

Practice Information

  • Specialty Hematology & Oncology
  • Location Philadelphia, PA
  • Active Since 08/31/2005
  • Last Updated 09/09/2013
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1588658942

Products in Payments

  • YONDELIS (Drug) $10,745
  • VOTRIENT (Drug) $125.00
  • PIPELINE (Device) $32.14

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Philadelphia